Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: GMP for clinical trials

The Role of NMPA GMP in Biopharmaceutical Manufacturing in China

Posted on December 10, 2024 By digi

The Role of NMPA GMP in Biopharmaceutical Manufacturing in China The Role of NMPA GMP in Biopharmaceutical Manufacturing in China Introduction to Biopharmaceutical Manufacturing and NMPA GMP Biopharmaceuticals, including vaccines, monoclonal antibodies, and gene therapies, have revolutionized the healthcare industry. These biologically derived drugs offer new treatments for previously untreatable diseases, but they also present…

Read More “The Role of NMPA GMP in Biopharmaceutical Manufacturing in China” »

NMPA GMP Guidelines

The Role of MHRA GMP in Clinical Trials and IMPs in the UK

Posted on December 10, 2024 By digi

The Role of MHRA GMP in Clinical Trials and IMPs in the UK Understanding the Role of MHRA GMP in Clinical Trials and Investigational Medicinal Products (IMPs) Introduction to MHRA GMP in Clinical Trials Clinical trials are a critical phase in drug development, where investigational medicinal products (IMPs) are tested for safety, efficacy, and optimal…

Read More “The Role of MHRA GMP in Clinical Trials and IMPs in the UK” »

MHRA GMP Guidelines

How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India

Posted on December 10, 2024 By digi

How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India Impact of Revised Schedule M GMP Guidelines on India’s Pharmaceutical Operations Introduction to Schedule M (Revised) and Its Significance India’s pharmaceutical industry has long been a global leader, supplying affordable and effective medications worldwide. However, ensuring that these products meet international safety and quality…

Read More “How Schedule M (Revised) GMP Guidelines Affect Pharmaceutical Operations in India” »

SCHEDULE - M - Revised

How to Achieve GMP Compliance According to PMDA Guidelines

Posted on December 10, 2024 By digi

How to Achieve GMP Compliance According to PMDA Guidelines How to Achieve GMP Compliance According to PMDA Guidelines Introduction to GMP Compliance and PMDA Guidelines Good Manufacturing Practice (GMP) is a set of regulatory guidelines that ensure pharmaceutical products are produced and controlled to the highest safety and quality standards. In Japan, the Pharmaceutical and…

Read More “How to Achieve GMP Compliance According to PMDA Guidelines” »

PMDA GMP Guidelines

The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing

Posted on December 9, 2024 By digi

The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing How EMA GMP Guidelines Safeguard Pharmaceutical Manufacturing from Contamination Introduction to Contamination Prevention in Pharma Contamination prevention is a critical aspect of pharmaceutical manufacturing, as it directly impacts product safety, efficacy, and regulatory compliance. The European Medicines Agency (EMA)’s Good Manufacturing Practices (GMP)) provide…

Read More “The Role of EMA GMP in Preventing Contamination in Pharmaceutical Manufacturing” »

EMA GMP Guidelines

How to Prepare for an ANVISA GMP Inspection in Brazil

Posted on December 9, 2024 By digi

How to Prepare for an ANVISA GMP Inspection in Brazil How to Prepare for an ANVISA GMP Inspection in Brazil Introduction to ANVISA GMP Inspections In Brazil, the National Health Surveillance Agency (ANVISA) is the regulatory authority responsible for ensuring the safety, efficacy, and quality of pharmaceutical products. One of the key aspects of maintaining…

Read More “How to Prepare for an ANVISA GMP Inspection in Brazil” »

GMP in Latin America (ANVISA, COFEPRIS)

How to Achieve Compliance with NMPA GMP Guidelines

Posted on December 9, 2024 By digi

How to Achieve Compliance with NMPA GMP Guidelines Achieving Compliance with NMPA GMP Guidelines for Pharmaceutical Manufacturing Introduction to NMPA GMP Compliance In China, the pharmaceutical industry is tightly regulated to ensure that drugs are produced under safe, consistent, and high-quality conditions. The National Medical Products Administration (NMPA), formerly known as the China Food and…

Read More “How to Achieve Compliance with NMPA GMP Guidelines” »

NMPA GMP Guidelines

MHRA GMP Guidelines for Biopharmaceutical Manufacturing

Posted on December 9, 2024 By digi

MHRA GMP Guidelines for Biopharmaceutical Manufacturing Comprehensive Insights into MHRA GMP Guidelines for Biopharmaceutical Manufacturing Introduction to MHRA GMP in Biopharmaceuticals Biopharmaceutical manufacturing involves the production of complex biologic drugs derived from living organisms. These products, including monoclonal antibodies, vaccines, and gene therapies, demand stringent quality control and regulatory oversight due to their intricate nature…

Read More “MHRA GMP Guidelines for Biopharmaceutical Manufacturing” »

MHRA GMP Guidelines

PMDA GMP Compliance: Key Elements for Pharmaceutical Companies

Posted on December 9, 2024 By digi

PMDA GMP Compliance: Key Elements for Pharmaceutical Companies PMDA GMP Compliance: Key Elements for Pharmaceutical Companies Introduction to PMDA GMP Compliance Good Manufacturing Practice (GMP) is essential in the pharmaceutical industry to ensure that drugs are consistently produced and controlled according to quality standards. In Japan, the Pharmaceutical and Medical Devices Agency (PMDA) enforces GMP…

Read More “PMDA GMP Compliance: Key Elements for Pharmaceutical Companies” »

PMDA GMP Guidelines

An Introduction to Schedule M (Revised) GMP Guidelines for Pharmaceutical Manufacturing

Posted on December 9, 2024 By digi

An Introduction to Schedule M (Revised) GMP Guidelines for Pharmaceutical Manufacturing Comprehensive Overview of Revised Schedule M Guidelines for Pharmaceutical Manufacturing What is Schedule M (Revised) and Why is it Important? The pharmaceutical industry in India is one of the largest globally, playing a crucial role in healthcare by providing affordable and effective medications. To…

Read More “An Introduction to Schedule M (Revised) GMP Guidelines for Pharmaceutical Manufacturing” »

SCHEDULE - M - Revised

Posts pagination

Previous 1 … 45 46 47 … 50 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme